1 / 41

An update on chronic renal failure: follow-up and when to refer ?

An update on chronic renal failure: follow-up and when to refer ?. Assoc Prof Johan Rosman Renal Department Waitemata DHB johan.rosman@waitematadhb.govt.nz Apollo Health Centre, Albany www.bloodpressure.org.nz. Chronic renal failure. Diagnosis Presentations and stages of CRF in general

cloris
Télécharger la présentation

An update on chronic renal failure: follow-up and when to refer ?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. An update on chronic renal failure: follow-up and when to refer ? Assoc Prof Johan Rosman Renal Department Waitemata DHB johan.rosman@waitematadhb.govt.nz Apollo Health Centre, Albany www.bloodpressure.org.nz

  2. Chronic renal failure • Diagnosis • Presentations and stages of CRF in general • Causes of CRF • Monitoring CRF • Consequences of CRF • Progression of CRF • Principles of treatment

  3. Short History (ds-wks) Normal Hb Normal renal size No osteodystrophy Periph neuropathy - Normal Ca and P Normal PTH Long history (mo-yrs) Low Hb Reduced renal size Often osteodystrophy Periph neuropathy + Low Ca / elevated P Increased PTH Differentiation acute-chronic renal failure

  4. Acute on chronic renal failure • Recrudescence of primary disease • Complication of primary disease • Accelerated hypertension • Volume depletion • Cardiac failure • Sepsis • Nephrotoxins (radiocontrast, drugs) • Renal artery occlusion • Urinary tract obstruction • Dietary protein load

  5. Presentation of CRF • Asymptomatic serum biochemical abnormality • Asymptomatic proteinuria/haematuria • Hypertension • Symptomatic primary disease • Symptomatic uraemia • Complications of renal failure

  6. Commonest causes of ESRF (ANZData) • Glomerulonephritis 30% • Diabetes 25% • Hypertension 10% • Polycystic kidney disease 5% • Vesicoureteral reflux 5% • Analgesic nephropathy 5% • Unknown 10% • Others 10%

  7. GFR (glomerular filtration rate) equals creatinine clearance ?? • The accurate assessment of GFR is desirable • Planning for the treatment of end stage renal disease • Referral to nephrology • Trace the course of progression of chronic renal disease or response to therapy • What is the best, most practical way to assess GFR?

  8. Creatinine: an imperfect marker Efferent arteriole Afferent arteriole Glomerulus Filtered Reabsorbed Secreted

  9. 200 400 600 800 1000 [Creatinine]s micromole/L 20 40 60 80 100 120 GFR ml/min/1.73m2 BSA

  10. “Normal” GFR by Age

  11. Measuring glom. filtration rate • Many formulas have attempted to predict GFR from a serum creatinine measurement only, most factoring in age, weight/height, and gender, which are all independent of serum creatinine in influencing GFR. • This would be the easiest approach clinically • a serum creatinine of 130 umol/l is normal in an athlete, but can mean dialysis dependency in a 80 year old !

  12. Aids in monitoring GFR (creat clearance) • Use the Cockroft Gault equation • Use the MDRD equation • But: in the follow up of a patient stick to the same way of estimating GFR • Formula’s for free available on the web (spreadsheet) or free for Palmtop (Medcalc) • Use 1/creatinine in individual patients to see whether a rise in creatinine represent an acute on chronic event

  13. Renal Screen • BP • MSU • RBC morphology; ACR; 24-hour proteinuria • Serum urea, creatinine, Na+, K+ • Ultrasound scan renal tract • Albumin, calcium, phosphate • PTH • eGFR

  14. Why do 24-hour urine collection? • Extremes of age / body size • Malnutrition or obesity • Catabolic states • Amputees / paraplegia / mm. wasting • Vegetarians / vegans • Pregnancy • Medication-dosing • Rapidly changing renal function

  15. Problems of ESRD • Cardiovascular disease • Anaemia • Renal Bone Disease • Metabolic acidosis • Malnutrition • Sodium and water • Potassium • Bleeding Diathesis • Dermatologic manifestations • Neurologic manifestations • Endocrine abnormalities • Immunity • Psychological manifestations

  16. Factors causing progression of CRF • Cont activity of primary disease • Systemic hypertension • Intraglomerular hypertension • Proteinuria • Nephrocalcinosis (dystr and metast) • Dyslipidaemia • Imbalance renal energy demands and supply

  17. No Proteinuria Cardiovascular Morbidity and Proteinuria Proteinuria 40 30 p < 0.001 Cumulative incidence (%) of CV morbidity 20 10 0 0 1 2 3 4 5 6 7 8 9 10 Years Adapted from Samuelsson et al. J Hypertens 1985;3:72 RPLM Hoogma

  18. Clinical trials of >3–years duration Relationship between BP and progression of CRF MAP (mm Hg) 98 100 102 104 106 108 110 0 r = 0.66; P<0.05 –2 –4 GFR (mL/min per year) –6 –8 –10 Adapted with permission from Bakris. Diabetes Res Clin Pract 1998;39:S35 RPLM Hoogma

  19. Principles of treatment of pat with CRF • Differentiate from ARF on CRF • Establish aetiology • Establish severity • Seek and treat reversible factors • Seek and treat complications • Lifestyle improvements • Seek and treat factors that promote progression • Planned and timely refer to nephrologist

  20. When to refer to renal physician? • eGFR < 30 ml/min/1.73m2 BSA • <45 in diabetics; anaemia (Hb < 100g/L) • Proteinuria > 1G per 24 hours • Glomerular haematuria • Difficult to control hypertension • Rapidly declining GFR • >15% in 3 months (Australia) • Electrolytes, vascular disease, etc.

  21. Early detection is paramount • CKD • Preventable • Growing @ 6%pa • Delayed progression • Renal abnormality is prevalent! • 16% of Australians (AusDIAB) • 15% NZers (Simmonds) • 20 x more likely to die than get RRT • Keith et al. Arch Int Med 164:659; 2004 • Asymptomatic

  22. The key to good care Communication Communication Communication 021- KIDNEY (021-543639)

More Related